Terms: = Gastric cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Treatment
26 results:
1. Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer.
Wang S; Yang X; Liu C; Hu J; Yan M; Ding C; Fu Y
Medicine (Baltimore); 2023 Oct; 102(40):e35111. PubMed ID: 37800754
[TBL] [Abstract] [Full Text] [Related]
2. Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma.
Moy RH; Greally M; Chou JF; Li J; Desai AM; Chalasani SB; Won E; Kelsen DP; Ilson DH; Janjigian YY; Capanu M; Ku GY
Cancer Chemother Pharmacol; 2022 Feb; 89(2):255-265. PubMed ID: 35066693
[TBL] [Abstract] [Full Text] [Related]
3. Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial.
Jeffers M; Kappeler C; Kuss I; Beckmann G; Mehnert DH; Fredebohm J; Teufel M
Gastric Cancer; 2022 May; 25(3):598-608. PubMed ID: 35050442
[TBL] [Abstract] [Full Text] [Related]
4. Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510.
Högner A; Al-Batran SE; Siveke JT; Lorenz M; Bartels P; Breithaupt K; Malfertheiner P; Homann N; Stein A; Gläser D; Tamm I; Hinke A; Vogel A; Thuss-Patience P;
Int J Cancer; 2022 Mar; 150(6):1007-1017. PubMed ID: 34741530
[TBL] [Abstract] [Full Text] [Related]
5. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
[TBL] [Abstract] [Full Text] [Related]
6. A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.
Zhou Y; Zhang X; Wu X; Zhou Y; Zhang B; Liu X; Wu X; Li Y; Shen L; Li J
Cancer Med; 2020 Sep; 9(17):6225-6233. PubMed ID: 32677196
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
Qi J; Liu HL; Ren F; Liu S; Shi W; Liu WH; Cai GQ; Liao GQ
World J Surg Oncol; 2020 Apr; 18(1):70. PubMed ID: 32264886
[TBL] [Abstract] [Full Text] [Related]
8. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
Ibrahim A; Chopra S
Arch Pathol Lab Med; 2020 May; 144(5):655-660. PubMed ID: 31169996
[TBL] [Abstract] [Full Text] [Related]
9. Hypomethylated gene NRP1 is co-expressed with pdgfrb and associated with poor overall survival in gastric cancer patients.
Wang G; Shi B; Fu Y; Zhao S; Qu K; Guo Q; Li K; She J
Biomed Pharmacother; 2019 Mar; 111():1334-1341. PubMed ID: 30841447
[TBL] [Abstract] [Full Text] [Related]
10. Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress.
Kim JL; Lee DH; Jeong S; Kim BR; Na YJ; Park SH; Jo MJ; Jeong YA; Oh SC
Oncol Rep; 2019 Mar; 41(3):1616-1626. PubMed ID: 30569109
[TBL] [Abstract] [Full Text] [Related]
11. Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases.
Hilberg F; Tontsch-Grunt U; Baum A; Le AT; Doebele RC; Lieb S; Gianni D; Voss T; Garin-Chesa P; Haslinger C; Kraut N
J Pharmacol Exp Ther; 2018 Mar; 364(3):494-503. PubMed ID: 29263244
[TBL] [Abstract] [Full Text] [Related]
12. Nilotinib Induced Recurrent gastric Polyps: Case Report and Review of Literature.
Kassem N; Ismail OM; Elomri H; Yassin MA
Am J Case Rep; 2017 Jul; 18():794-798. PubMed ID: 28706179
[TBL] [Abstract] [Full Text] [Related]
13. Quantitative proteomic analysis of gastric cancer tissue reveals novel proteins in platelet-derived growth factor b signaling pathway.
Liu F; Zhang Y; Men T; Jiang X; Yang C; Li H; Wei X; Yan D; Feng G; Yang J; Bergquist J; Wang B; Jiang W; Mi J; Tian G
Oncotarget; 2017 Mar; 8(13):22059-22075. PubMed ID: 28423550
[TBL] [Abstract] [Full Text] [Related]
14. gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies.
Majeed W; Iftikhar A; Khaliq T; Aslam B; Muzaffar H; Atta K; Mahmood A; Waris S
Asian Pac J Cancer Prev; 2016; 17(7):3053-60. PubMed ID: 27509928
[TBL] [Abstract] [Full Text] [Related]
15. Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy.
Minatsuki S; Miura I; Yao A; Abe H; Muraoka H; Tanaka M; Imamura T; Inaba T; Maki H; Hatano M; Kinugawa K; Yao T; Fukayama M; Nagai R; Komuro I
Int Heart J; 2015; 56(2):245-8. PubMed ID: 25740390
[TBL] [Abstract] [Full Text] [Related]
16. Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplification.
Kim ST; Jang HL; Lee SJ; Lee J; Choi YL; Kim KM; Cho J; Park SH; Park YS; Lim HY; Yashiro M; Kang WK; Park JO
Mol Cancer Ther; 2014 Nov; 13(11):2527-36. PubMed ID: 25249557
[TBL] [Abstract] [Full Text] [Related]
17. Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer.
Onoyama M; Kitadai Y; Tanaka Y; Yuge R; Shinagawa K; Tanaka S; Yasui W; Chayama K
Neoplasia; 2013 Dec; 15(12):1391-9. PubMed ID: 24403861
[TBL] [Abstract] [Full Text] [Related]
18. Tyrosine-kinase mutations in c-KIT and pdgfr-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
[TBL] [Abstract] [Full Text] [Related]
19. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.
Sumida T; Kitadai Y; Shinagawa K; Tanaka M; Kodama M; Ohnishi M; Ohara E; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2011 May; 128(9):2050-62. PubMed ID: 21387285
[TBL] [Abstract] [Full Text] [Related]
20. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma.
Kodama M; Kitadai Y; Sumida T; Ohnishi M; Ohara E; Tanaka M; Shinagawa K; Tanaka S; Yasui W; Chayama K
Cancer Sci; 2010 Sep; 101(9):1984-9. PubMed ID: 20624165
[TBL] [Abstract] [Full Text] [Related]
[Next]
